49 Wealth Management, LLC Inozyme Pharma, Inc. Transaction History
49 Wealth Management, LLC
- $830 Billion
- Q1 2025
A detailed history of 49 Wealth Management, LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, 49 Wealth Management, LLC holds 41,850 shares of INZY stock, worth $42,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,850Holding current value
$42,268% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INZY
# of Institutions
105Shares Held
50.6MCall Options Held
2.6KPut Options Held
5.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.16MShares$5.21 Million0.03% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$4.54 Million11.45% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$4.32 Million0.97% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.97MShares$4.01 Million1.97% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.86MShares$3.9 Million0.43% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $40.5M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...